A Phase 3 Study to Evaluate the Safety and Efficacy of New Therapy in Subjects with Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Formulary Therapy

October 16, 2018
https://clinicaltrials.gov/ct2/show/NCT03602560
Gastroenterology Hepatology
Principal Investigator: Stuart C Gordon, MD
PBC, pbc, primary biliary cholangitis, Primary Biliary Cholangitis, primary biliary cirrhosis
Open